FDA Grants Breakthrough Therapy Designation to MDMA (Ecstasy) for PTSD

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA (the main compound found in ecstasy) for the treatment of posttraumatic stress disorder (PTSD).

The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of posttraumatic stress disorder (PTSD). MAPS and the FDA have also reached agreement under the Special Protocol Assessment Process (SPA) for the design of two upcoming Phase 3 trials (MAPP1 and MAPP2) of MDMA-assisted psychotherapy for patients with severe PTSD.

MDMA-assisted psychotherapy is a novel treatment package that combines psychotherapeutic techniques with three administrations of MDMA as a pharmacological adjunct.

Read moreFDA Grants Breakthrough Therapy Designation to MDMA (Ecstasy) for PTSD

Colorado Senate Votes 34 to 1 to Allow Medical Marijuana for PTSD and Acute Stress Disorder

Colorado’s full Senate has voted to allow those with post traumatic stress disorder and acute stress disorder to legally use medical marijuana.

Senate Bill 17-017 passed the Senate with a 34 to 1 vote.┬áSenator Kent Lambert (R) cast the sole “No” vote. The measure has been sent to the House of Representatives, and assigned to the State, Veterans, & Military Affairs Committee. Passage through the House will send it to Governor John Hickenlooper for consideration.

According to its legislative summary; “The bill creates a statutory right to use medical marijuana for a patient with acute stress disorder or post-traumatic stress disorder. The bill creates the same rights, limitations, and criminal defenses and exceptions as the constitutional right to use medical marijuana.”

Read moreColorado Senate Votes 34 to 1 to Allow Medical Marijuana for PTSD and Acute Stress Disorder